These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1056 related items for PubMed ID: 18240235
1. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. Landau DA, Saadoun D, Halfon P, Martinot-Peignoux M, Marcellin P, Fois E, Cacoub P. Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235 [Abstract] [Full Text] [Related]
2. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, Myers RP, Leger JM, Servan J, Piette JC. Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738 [Abstract] [Full Text] [Related]
3. Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus. Saadoun D, Aaron L, Resche-Rigon M, Pialoux G, Piette JC, Cacoub P, GERMIVIC Study Group. AIDS; 2006 Apr 04; 20(6):871-7. PubMed ID: 16549971 [Abstract] [Full Text] [Related]
4. Longterm efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection. Naarendorp M, Kallemuchikkal U, Nuovo GJ, Gorevic PD. J Rheumatol; 2001 Nov 04; 28(11):2466-73. PubMed ID: 11708420 [Abstract] [Full Text] [Related]
5. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy. Mazzaro C, Carniello GS, Colle R, Doretto P, Mazzi G, Crovatto M, Santini GF, Tulissi P, Gregoretti M, Mazzoran L, Russo A, Silvestri F, Pozzato G. Ital J Gastroenterol Hepatol; 1997 Aug 04; 29(4):343-50. PubMed ID: 9476189 [Abstract] [Full Text] [Related]
6. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders. Terrier B, Sène D, Saadoun D, Ghillani-Dalbin P, Thibault V, Delluc A, Piette JC, Cacoub P. Ann Rheum Dis; 2009 Jan 04; 68(1):89-93. PubMed ID: 18375535 [Abstract] [Full Text] [Related]
7. Ribavirin in hepatitis C related cryoglobulinemia. Durand JM, Cacoub P, Lunel-Fabiani F, Cosserat J, Cretel E, Kaplanski G, Frances C, Bletry O, Soubeyrand J, Godeau P. J Rheumatol; 1998 Jun 04; 25(6):1115-7. PubMed ID: 9632073 [Abstract] [Full Text] [Related]
8. Chronic hepatitis C virus infection in renal transplant: treatment and outcome. Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N. Clin Transplant; 2006 Jun 04; 20(6):677-83. PubMed ID: 17100715 [Abstract] [Full Text] [Related]
9. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C. De Mitri MS, Morsica G, Chen CH, Mele L, Baccarini P, Chianese R, Piccinini A, Lazzarin A, Pisi E. Ital J Gastroenterol Hepatol; 1997 Jun 04; 29(3):255-61. PubMed ID: 9646218 [Abstract] [Full Text] [Related]
10. Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapy. Kessler HH, Pierer K, Santner BI, Vellimedu SK, Stelzl E, Marth E, Fickert P, Stauber RE. J Hum Virol; 1998 Jun 04; 1(5):314-9. PubMed ID: 10195258 [Abstract] [Full Text] [Related]
11. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J, Wilkinson J, Adair D, Rakela J, Laskus T. Hepatology; 2005 Jan 04; 41(1):106-14. PubMed ID: 15619235 [Abstract] [Full Text] [Related]
12. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection. Antonelli A, Ferri C, Fallahi P, Ferrari SM, Sebastiani M, Ferrari D, Giunti M, Frascerra S, Tolari S, Franzoni F, Galetta F, Marchi S, Ferrannini E. Am J Gastroenterol; 2008 Oct 04; 103(10):2488-94. PubMed ID: 18775023 [Abstract] [Full Text] [Related]
13. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy. Mazzaro C, Franzin F, Tulissi P, Pussini E, Crovatto M, Carniello GS, Efremov DG, Burrone O, Santini G, Pozzato G. Cancer; 1996 Jun 15; 77(12):2604-13. PubMed ID: 8640712 [Abstract] [Full Text] [Related]
14. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response. Chu CM, Sheen IS, Liaw YF. Infection; 2004 Jun 15; 32(3):153-6. PubMed ID: 15188075 [Abstract] [Full Text] [Related]
15. Early prediction of hepatitis C virus (HCV) infection relapse in nonresponders to primary interferon therapy by means of HCV RNA whole-blood analysis. Watkins-Riedel T, Ferenci P, Steindl-Munda P, Gschwantler M, Mueller C, Woegerbauer M. Clin Infect Dis; 2004 Dec 15; 39(12):1754-60. PubMed ID: 15578395 [Abstract] [Full Text] [Related]
16. Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy. Januszkiewicz-Lewandowska D, Wysocki J, Pernak M, Nowicka K, Zawada M, Rembowska J, Lewandowski K, Mańkowski P, Nowak J. Jpn J Infect Dis; 2007 Feb 15; 60(1):29-32. PubMed ID: 17314422 [Abstract] [Full Text] [Related]
17. Late disappearance of hepatitis C virus RNA from peripheral blood mononuclear cells in patients with chronic hepatitis C in sustained response after alpha-interferon therapy. García-Bengoechea M, Basaras M, Barrio J, Arrese E, Montalvo II, Arenas JI, Cisterna R. Am J Gastroenterol; 1999 Jul 15; 94(7):1902-5. PubMed ID: 10406257 [Abstract] [Full Text] [Related]
18. The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders. Landau DA, Rosenzwajg M, Saadoun D, Klatzmann D, Cacoub P. Ann Rheum Dis; 2009 Mar 15; 68(3):337-44. PubMed ID: 18434450 [Abstract] [Full Text] [Related]
19. Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays. Sarrazin C, Teuber G, Kokka R, Rabenau H, Zeuzem S. Hepatology; 2000 Oct 15; 32(4 Pt 1):818-23. PubMed ID: 11003628 [Abstract] [Full Text] [Related]
20. Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment. Comanor L, Anderson F, Ghany M, Perrillo R, Heathcote EJ, Sherlock C, Zitron I, Hendricks D, Gordon SC. Am J Gastroenterol; 2001 Oct 15; 96(10):2968-72. PubMed ID: 11693334 [Abstract] [Full Text] [Related] Page: [Next] [New Search]